Drugs / PN-943
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04504383 | Aug 2020 → Feb 2023 | ulcerative colitis | Protagonist Therapeutics, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PN-943 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04504383 ↗ |
| Route | Oral | “Administered by the oral route BID for the duration of the study.” NCT04504383 ↗ |